Company / Interest Expense
Haemonetics Interest Expense History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$35.9M
FY2024
5-year range
$5.8M / $35.9M
FY2020-FY2024
Trend
+84.1%
vs FY2023
Sector context
#27 of 40
Health Care
What the data says
At $36M, Haemonetics's interest expense ranks #14 of 40 in the Health Care sector. Interest Expense has increased for 3 consecutive years, from $6M in FY2021 to $36M in FY2024.
Based on SEC 10-K filings.
$36M in FY2024 with a 5-year CAGR of +21.6%.
Increased from $13M to $36M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +83.6%
- 5-Year CAGR
- +21.6%
- 10-Year CAGR
- -
Sector benchmark
#14 of 40 in Health CareTop 32% of 40This company $35.9M Sector average $332.7M
▼
-89.2% below sector average
Key checks
Key Insights
- Haemonetics's interest expense has grown for 3 consecutive years.
- 5-year CAGR of +21.6%, indicating consistent growth.
- In FY2024, interest expense increased 84.1% year-over-year.
- Ranks #27 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $35.9M | +84.1% |
| FY2023 | $19.5M | +50.0% |
| FY2022 | $13.0M | +124.1% |
| FY2021 | $5.8M | -38.3% |
| FY2020 | $9.4M | -30.4% |
| FY2019 | $13.5M | +7.1% |
| FY2018 | $12.6M | +63.6% |
| FY2017 | $7.7M | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026